Connor, Clark & Lunn Investment Management Ltd. X Biotech Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in X Biotech Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 74,194 shares of XBIT stock, worth $247,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,194
Previous 75,715
2.01%
Holding current value
$247,807
Previous $585,000
49.91%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XBIT
# of Institutions
51Shares Held
4.86MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$3.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.56 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$1.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$938,6030.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$847,5910.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $102M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...